TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search results
COVID-19 patients with pneumonia improved faster when treated with Vanda Pharmaceuticals Inc's experimental therapy than those on placebo, the company said on Tuesday, citing an interim analysis of data from a late-stage study.
South Korea's Daewoong Pharmaceutical Co Ltd said on Tuesday it received Indian regulatory approval to test its anti-parasitic niclosamide drug to treat COVID-19 patients in an early-stage human trial.
Taiwan provisionally approved the use of dexamethasone, a cheap and widely-used steroid, to treat the new coronavirus, as the island faces a shortfall of the antiviral drug remdesivir after the United States bought nearly all global supplies.
A research team at a temporary COVID-19 hospital at Wisma Atlet Kemayoran in Central Jakarta has reportedly managed to recruit its 90th and final subject for its clinical trials of new herbal medicines for COVID-19 patients. Seventy-two of them have completed the trials so far.
US drugmaker Eli Lilly & Co is beginning a late-stage trial to study whether one of its experimental COVID-19 antibody treatments can prevent the spread of the virus in residents and staff at US nursing homes, it said on Monday.
Rival drugmakers AbbVie Inc, Amgen Inc and Takeda Pharmaceuticals Inc on Monday said they have begun treating patients in a trial to quickly show whether a drug from each company can be repurposed and used against COVID-19, the disease caused by the novel coronavirus.
